Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 Next >
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
Tickers IONS TSM UNH
Tags NASDAQ:IONS,NYSE:UNH,NYSE:TSM TSM IONS
From InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
Tickers ALNY AZN IONS NEWS
Tags Biotech Benzinga Expert Ideas
From Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
Tickers AZN IONS NEWS
Tags Market News why it's moving AZN
From Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
Tickers IONS TAK
Tags Benzinga Biotech Briefs
From Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
Tickers IONS
Tags Analyst Ratings BZI/AAR IONS
From Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
Tickers ARKG ARKK ARKQ DKNG
Tags sports betting ARKQ ARKG
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags IONS BZI/AAR Analyst Ratings
From Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
Tickers ARKG ARKK CRSP EVS
Tags TSLA Equities News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Tickers ABBV ADBE ADSK AKAM
Tags EAT ADSK FUSN
From Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
Tickers ALNY AZN IONS NVS
Tags RHHBY AZN Contracts
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Market News Benzinga IONS
From Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
Tickers IONS
Tags why it's moving IONS Market News
From Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
Tickers IONS
Tags Health Care Benzinga Movers
From Benzinga
The 7 Most Hated Stocks by Institutional Traders
Tickers GS IONS LLY PDD
Tags Stocks to Sell LLY NASDAQ:PTON,NYSE:TOST,NASDAQ:IONS,NASDAQ:TMUS,NASDAQ:PDD,NYSE:GS,NYSE:LLY
From InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
Tickers ALNY IONS RHHBF RHHBY
Tags IONS RHHVF General
From Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Tickers ACCD ARKG ARKK ARKW
Tags Genius Sports DraftKings IONS
From Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
Tickers ALNY AZN IONS
Tags Analyst Ratings AZN Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Tickers A ABR ADBE AIV
Tags MTX PRME WAT
From Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Tickers AAPL ADBE BAX CMCSA
Tags BAX ADBE Analyst Ratings
From Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
Tickers BIIB IONS NVS
Tags News Briefs Equities
From Benzinga
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
Tickers IONS NTLA
Tags NTLA Trading Ideas Health Care
From Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
Tickers AZN IONS
Tags Expert Ideas Price Target Briefs
From Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
Tickers IONS
Tags why it's moving IONS Market News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Market News Benzinga BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags RVLV BLDR Benzinga
From Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
Tickers IONS
Tags Market News Earnings Benzinga
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags IONS BZI/EP Market News
From Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
Tickers BIIB IONS
Tags Large Cap News Biotech
From Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
Tickers BIIB IONS
Tags IONS BIIB
From MarketWatch
What's Going On With Biogen Stock Tuesday?
Tickers BIIB IONS
Tags News Movers Benzinga
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.